Mumbai institute study indicates women prefer bimonthly injectable contraceptivePublished On: Mon, Apr 30th, 2007 | Women Health | By BioNews
April 30 : Injectable contraceptives are gaining popularity among women across the country, says a study conducted by the National Institute for Research in Reproductive Health (NIRRH), Mumbai.
Preliminary observations based on the study involving 15,228 women said that almost 90 percent of them wanted injectable contraceptives to be made available in the National Family Welfare Programme as they find it were convenient than the pills.
The study aims to find out the acceptability of bimonthly injectable contraceptive â€“ norethisterone enanthate (Net-En) â€“ among women across the country.
At the end of one year, it was observed that 65 per cent women continued the use of injections.
However, the number of women using injections, dipped by 11 percent in another six months, as only 54 percent continued to use them.
During the survey period of two years, 409 women used injections.
The reason for lower number of women continuing with the injections, the study said, was due to discrepancy in follow-up owing to floating population.
Over 80 percent women were satisfied with the use of this method and 79 per cent recommended the same to their friends and relatives.
Keeping in mind that women’s groups and health activists had raised issues about decrease in bone-mass-density (BMD) among women who used depo-provera, a trimonthly injectable contraceptive, NIRRH has initiated BMD evaluation of women using bi-monthly Net-En injection.
Women health groups have been opposed to the introduction of injectable contraceptives in the National Family Planning Programme citing the potential for their abuse as the reason.
They say mandatory trials for the effectiveness and side-effect should be conducted before introducing them in the programme. (ANI)